Celularity Correlations
| CELUW Stock | USD 0.05 0.01 9.42% |
The current 90-days correlation between Celularity and Crispr Therapeutics AG is 0.04 (i.e., Significant diversification). The correlation of Celularity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Celularity Correlation With Market
Significant diversification
The correlation between Celularity and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Celularity and DJI in the same portfolio, assuming nothing else is changed.
Celularity | Build AI portfolio with Celularity Stock |
Moving against Celularity Stock
| 0.35 | KO | Coca Cola Earnings Call This Week | PairCorr |
Related Correlations Analysis
| 0.92 | 0.82 | 0.43 | 0.85 | 0.97 | CRBU | ||
| 0.92 | 0.87 | 0.61 | 0.95 | 0.94 | CRSP | ||
| 0.82 | 0.87 | 0.37 | 0.82 | 0.81 | VERV | ||
| 0.43 | 0.61 | 0.37 | 0.7 | 0.51 | BEAM | ||
| 0.85 | 0.95 | 0.82 | 0.7 | 0.9 | PRME | ||
| 0.97 | 0.94 | 0.81 | 0.51 | 0.9 | SANA | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Celularity Stock performing well and Celularity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Celularity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CRBU | 5.41 | 1.36 | 0.24 | 0.77 | 4.79 | 12.02 | 23.18 | |||
| CRSP | 2.85 | 0.66 | 0.22 | 0.56 | 2.83 | 7.09 | 16.14 | |||
| VERV | 5.11 | 1.90 | 0.41 | 12.27 | 3.30 | 9.30 | 83.78 | |||
| BEAM | 2.87 | 0.18 | 0.05 | 0.24 | 4.23 | 6.28 | 26.62 | |||
| PRME | 6.84 | 1.82 | 0.30 | 1.04 | 5.67 | 21.58 | 41.91 | |||
| SANA | 4.85 | 1.42 | 0.36 | 1.02 | 3.47 | 12.50 | 31.62 |
Celularity Corporate Management
| Carlos Ramirez | SVP Relations | Profile | |
| Sharmila MD | Senior Safety | Profile | |
| CFA CFA | Chief Officer | Profile | |
| Tim Wilk | Senior Operations | Profile | |
| Ramji Krishnan | Chief Officer | Profile | |
| Bradley Glover | Ex COO | Profile | |
| CPA MS | Treasurer | Profile |